In the presence of hyperinsulinemia and high IGF levels, cancer cells upregulate insulin and IGF-1 receptors, resulting in the stimulation of signaling pathways that are closely related to mitogenesis, cell growth, and migration [19, 20]. The gene discussed is INS; the disease is hyperinsulinism.